Researchers: Night Vision Tests in AMD Precisely Localize Disease Mechanisms

Researchers at the University of Alabama at Birmingham discovered that night vision tests at a specific location in the retina will be suitable for assessing treatments and preventions for age-related macular degeneration (AMD), according to a university article.

Cynthia Owsley, PhD, and Christine Curcio, PhD, (UAB) lead the Alabama Study on Early Age-related Macular Degeneration (ALSTAR2). This NEI-funded project prospectively assesses >500 persons over 3 years to determine the best vision test for signaling disease onset and worsening. The study is notable for its large size and focus on early disease.

These findings are published in "Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration: Alabama Study on Early Age-related Macular Degeneration 2 Baseline" in the June 2023 issue of Ophthalmology Science.